The Million Hearts payment model, which incentivizes healthcare organizations to reduce cardiovascular risk among Medicare beneficiaries, led to a modest but significant reduction in new-onset myocardial infarctions and strokes over five years. The model did not result in a significant increase in Medicare spending, suggesting a cost-effective way to improve cardiovascular health.
Frontier Medicines raises $80M, enters clinic and eyes potential IPO in Q4 or early 2025
Frontier Medicines, a bicoastal biotech creating covalent small molecules, has secured $80 million in Series C funds and dosed the first patient in its initial
February 23, 2024